ANG Lifesciences

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE236W01016
NSEID:
BSEID: 540694

INR

28.30

-0.51 (-1.77%)

BSENSE

Dec 05

BSE+NSE Vol: 5.48 k

{
  "main_header": {
    "sid": 1002820,
    "name": "ANG Lifesciences",
    "stock_name": "ANG Lifesciences",
    "full_name": "ANG Lifesciences India Ltd",
    "name_url": "stocks-analysis/ang-lifesciences",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "28.30",
    "chg": -0.51,
    "chgp": "-1.77%",
    "dir": -1,
    "prev_price": "28.81",
    "mcapval": "38.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540694,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE236W01016",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "5.48 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ang-lifesciences-1002820-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "ANG Lifesciences India Surges with Unprecedented Buying Interest, Hits Upper Circuit",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-hits-upper-circuit-amid-unprecedented-buying-interest-3737724",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ANGLifesciences_only_buyers_3737724.png",
        "date": "2025-12-01 09:31:18",
        "description": "ANG Lifesciences India has witnessed extraordinary buying momentum, hitting the upper circuit with only buy orders in the queue. The stock’s performance today stands out sharply against the broader market, reflecting a rare scenario of sustained demand and no selling pressure, potentially signalling a multi-day circuit phenomenon."
      },
      {
        "title": "Why is ANG Lifesciences falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-ang-lifesciences-fallingrising-3736244",
        "imagepath": "",
        "date": "2025-11-29 01:02:50",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Movement and Market Context</strong></p>\n<p>ANG Lifesciences has recorded a consecutive three-day rally, accumulating a 15.67% return during this period. Today's session opened with a gap up of 4.95%, signalling strong buying interest at the outset. The stock outperformed its sector by 4.44% today, indicating relative strength compared to its peers. Intraday, the price fluctuated between a low of ₹25.70 and a high of ₹27.98, ultimately settling at the day's peak level.</p>\n<p>Despite this recent upswing, the stock's longer-term performance remains subdued. Year-to-date, ANG Lifesciences has declined by 37.39%, contrasting sharply with the Sensex's 9.68% gain over the same period. Over one year, the stock is down 37.82%, while the Sensex has advanced 8.43%. The three-year tre..."
      },
      {
        "title": "ANG Lifesciences India Sees Unprecedented Buying Interest Amid Upper Circuit Lock",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-hits-upper-circuit-amid-unprecedented-buying-interest-3735403",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ANGLifesciences_only_buyers_3735403.png",
        "date": "2025-11-28 10:20:36",
        "description": "ANG Lifesciences India has witnessed extraordinary buying momentum, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon signals intense demand and the possibility of a multi-day circuit scenario, drawing significant attention from investors and market watchers alike."
      },
      {
        "title": "ANG Lifesciences India Sees Unprecedented Buying Interest, Hits Upper Circuit",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-hits-upper-circuit-amid-unprecedented-buying-interest-3732947",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ANGLifesciences_only_buyers_3732947.png",
        "date": "2025-11-27 09:41:34",
        "description": "ANG Lifesciences India has witnessed extraordinary buying momentum today, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon highlights intense demand and the possibility of a sustained multi-day circuit scenario, setting the stage for close investor attention in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "ANG Lifesciences India Sees Extraordinary Buying Interest Amid Upper Circuit Scenario",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-hits-upper-circuit-amid-unprecedented-buying-interest-3731342",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ANGLifesciences_only_buyers_3731342.png",
        "date": "2025-11-26 11:45:33",
        "description": "ANG Lifesciences India has witnessed a remarkable surge in buying activity, with the stock hitting the upper circuit and registering only buy orders in the queue. This unusual market behaviour signals intense demand and the possibility of a multi-day circuit scenario, drawing significant attention from investors and market watchers alike."
      },
      {
        "title": "ANG Lifesciences India Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-faces-severe-selling-pressure-amid-prolonged-downtrend-3728379",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ANGLifesciences_only_sellers_3728379.png",
        "date": "2025-11-25 10:20:55",
        "description": "ANG Lifesciences India is experiencing severe selling pressure, with the stock registering a sharp decline of 4.99% today and no buyers visible in the order book. This marks the seventh consecutive day of losses, reflecting a sustained period of distress selling that has significantly impacted the stock’s performance across multiple time frames."
      },
      {
        "title": "ANG Lifesciences India Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-faces-severe-selling-pressure-amid-prolonged-downtrend-3724294",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ANGLifesciences_only_sellers_3724294.png",
        "date": "2025-11-24 09:55:48",
        "description": "ANG Lifesciences India is currently experiencing severe selling pressure, with the stock registering a lower circuit and an absence of buyers on the order book. The pharmaceutical and biotechnology company has seen a continuous decline over the past week, signalling distress selling and heightened market caution."
      },
      {
        "title": "ANG Lifesciences India Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-faces-severe-selling-pressure-amid-prolonged-downtrend-3720695",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ANGLifesciences_only_sellers_3720695.png",
        "date": "2025-11-21 11:00:44",
        "description": "ANG Lifesciences India is currently experiencing severe selling pressure, with the stock registering a fifth consecutive day of losses and no buyers visible in the order book. The pharmaceutical and biotechnology company’s shares have underperformed the broader market significantly, signalling distress selling and a challenging outlook for investors."
      },
      {
        "title": "How has been the historical performance of ANG Lifesciences?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-ang-lifesciences-3703749",
        "imagepath": "",
        "date": "2025-11-15 00:11:59",
        "description": "Answer:\nThe historical performance of ANG Lifesciences shows a significant decline in net sales and profitability over the past few years.\n\nBreakdown:\nANG Lifesciences experienced a decrease in net sales from INR 354.30 crore in March 2022 to INR 92.85 crore in March 2025. This downward trend is mirrored in total operating income, which fell from INR 354.30 crore in March 2022 to the same INR 92.85 crore in March 2025. The company's operating profit (PBDIT) also declined sharply, moving from a profit of INR 68.28 crore in March 2022 to a loss of INR 0.25 crore in March 2025. Profit before tax followed a similar trajectory, dropping from INR 53.50 crore in March 2022 to a loss of INR 15.70 crore in March 2025. Consequently, profit after tax also turned negative, going from a profit of INR 40.32 crore in March 2022 to a loss of INR 12.41 crore in March 2025. The company's total assets decreased from INR 286.7..."
      }
    ],
    "total": 282,
    "sid": "1002820",
    "stock_news_url": "https://www.marketsmojo.com/news/ang-lifesciences-india-1002820"
  },
  "announcements": [
    {
      "caption": "Unaudited Financial Results For The Quarter And Half Year Ended 30-09-2025",
      "datetime": "14-Nov-2025",
      "details": "Unaudited Financial Results for the Quarter and Half year ended 30.09.2025.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Board Meeting Outcome For To Consider And Approve The Financial Results For The Quarter And Half Year Ended 30-09-2025",
      "datetime": "14-Nov-2025",
      "details": "Considered and approved the financial results for the quarter and half year ended 30th September 2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended On 30Th September 2025.",
      "datetime": "06-Nov-2025",
      "details": "ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve Pursuant to the Regulation 29 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015 It is hereby informed you that the meeting of the Board of Directors of the Company is scheduled to be held on Friday 14th November 2025 at 05:00 P.M. at the Registered Office of the Company situated at Darbara Complex SCO-113 District Shopping Centre B Block Ranjit Avenue Amritsar-143001 inter alia transact the following business: 1. To consider and approve the Standalone and Consolidated Un-Audited Financial Results of the Company for the quarter and half year ended 30th September 2025. 2. Any other business that may be necessary with the permission of Chairman.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "ANG Lifesciences India Ltd has declared <strong>10%</strong> dividend, ex-date: 02 Nov 21",
          "dt": "2021-11-02",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "ANG Lifesciences India Ltd has announced <strong>1:4</strong> bonus issue, ex-date: 13 Jul 22",
          "dt": "2022-07-13",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

ANG Lifesciences India Surges with Unprecedented Buying Interest, Hits Upper Circuit

2025-12-01 09:31:18

ANG Lifesciences India has witnessed extraordinary buying momentum, hitting the upper circuit with only buy orders in the queue. The stock’s performance today stands out sharply against the broader market, reflecting a rare scenario of sustained demand and no selling pressure, potentially signalling a multi-day circuit phenomenon.

Why is ANG Lifesciences falling/rising?

2025-11-29 01:02:50

Short-Term Price Movement and Market Context

ANG Lifesciences has recorded a consecutive three-day rally, accumulating a 15.67% return during this period. Today's session opened with a gap up of 4.95%, signalling strong buying interest at the outset. The stock outperformed its sector by 4.44% today, indicating relative strength compared to its peers. Intraday, the price fluctuated between a low of ₹25.70 and a high of ₹27.98, ultimately settling at the day's peak level.

Despite this recent upswing, the stock's longer-term performance remains subdued. Year-to-date, ANG Lifesciences has declined by 37.39%, contrasting sharply with the Sensex's 9.68% gain over the same period. Over one year, the stock is down 37.82%, while the Sensex has advanced 8.43%. The three-year tre...

ANG Lifesciences India Sees Unprecedented Buying Interest Amid Upper Circuit Lock

2025-11-28 10:20:36

ANG Lifesciences India has witnessed extraordinary buying momentum, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon signals intense demand and the possibility of a multi-day circuit scenario, drawing significant attention from investors and market watchers alike.

ANG Lifesciences India Sees Unprecedented Buying Interest, Hits Upper Circuit

2025-11-27 09:41:34

ANG Lifesciences India has witnessed extraordinary buying momentum today, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon highlights intense demand and the possibility of a sustained multi-day circuit scenario, setting the stage for close investor attention in the Pharmaceuticals & Biotechnology sector.

ANG Lifesciences India Sees Extraordinary Buying Interest Amid Upper Circuit Scenario

2025-11-26 11:45:33

ANG Lifesciences India has witnessed a remarkable surge in buying activity, with the stock hitting the upper circuit and registering only buy orders in the queue. This unusual market behaviour signals intense demand and the possibility of a multi-day circuit scenario, drawing significant attention from investors and market watchers alike.

ANG Lifesciences India Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-25 10:20:55

ANG Lifesciences India is experiencing severe selling pressure, with the stock registering a sharp decline of 4.99% today and no buyers visible in the order book. This marks the seventh consecutive day of losses, reflecting a sustained period of distress selling that has significantly impacted the stock’s performance across multiple time frames.

ANG Lifesciences India Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-24 09:55:48

ANG Lifesciences India is currently experiencing severe selling pressure, with the stock registering a lower circuit and an absence of buyers on the order book. The pharmaceutical and biotechnology company has seen a continuous decline over the past week, signalling distress selling and heightened market caution.

ANG Lifesciences India Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-21 11:00:44

ANG Lifesciences India is currently experiencing severe selling pressure, with the stock registering a fifth consecutive day of losses and no buyers visible in the order book. The pharmaceutical and biotechnology company’s shares have underperformed the broader market significantly, signalling distress selling and a challenging outlook for investors.

How has been the historical performance of ANG Lifesciences?

2025-11-15 00:11:59

Answer: The historical performance of ANG Lifesciences shows a significant decline in net sales and profitability over the past few years. Breakdown: ANG Lifesciences experienced a decrease in net sales from INR 354.30 crore in March 2022 to INR 92.85 crore in March 2025. This downward trend is mirrored in total operating income, which fell from INR 354.30 crore in March 2022 to the same INR 92.85 crore in March 2025. The company's operating profit (PBDIT) also declined sharply, moving from a profit of INR 68.28 crore in March 2022 to a loss of INR 0.25 crore in March 2025. Profit before tax followed a similar trajectory, dropping from INR 53.50 crore in March 2022 to a loss of INR 15.70 crore in March 2025. Consequently, profit after tax also turned negative, going from a profit of INR 40.32 crore in March 2022 to a loss of INR 12.41 crore in March 2025. The company's total assets decreased from INR 286.7...

View All News

Announcement

Unaudited Financial Results For The Quarter And Half Year Ended 30-09-2025

14-Nov-2025 | Source : BSE

Unaudited Financial Results for the Quarter and Half year ended 30.09.2025.

Board Meeting Outcome for Board Meeting Outcome For To Consider And Approve The Financial Results For The Quarter And Half Year Ended 30-09-2025

14-Nov-2025 | Source : BSE

Considered and approved the financial results for the quarter and half year ended 30th September 2025

Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended On 30Th September 2025.

06-Nov-2025 | Source : BSE

ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve Pursuant to the Regulation 29 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015 It is hereby informed you that the meeting of the Board of Directors of the Company is scheduled to be held on Friday 14th November 2025 at 05:00 P.M. at the Registered Office of the Company situated at Darbara Complex SCO-113 District Shopping Centre B Block Ranjit Avenue Amritsar-143001 inter alia transact the following business: 1. To consider and approve the Standalone and Consolidated Un-Audited Financial Results of the Company for the quarter and half year ended 30th September 2025. 2. Any other business that may be necessary with the permission of Chairman.